Patent application number | Description | Published |
20080234267 | Compounds and Methods of Treatment - A derivative, which is useful as a ret kinase inhibitor is described herein. The described invention also includes methods of using the same in the treatment of diseases mediated by inappropriate ret kinase activity. | 09-25-2008 |
20100249160 | Cancer Treatment Method - A method of treating cancer is described including administration of a 4-quinazolineamine and at least one other anti-neoplastic agent as well as a pharmaceutical combination including the 4-quinazolineamines. | 09-30-2010 |
20110312982 | Cancer Treatment Method - A method of treating cancer is described including administration of a 4-quinazolinamine and at least one other anti-neoplastic agent as well as a pharmaceutical combination including the 4-quinazolinamines. | 12-22-2011 |
20120058113 | CANCER TREATMENT METHOD - A method of treating cancer is described including administration of a 4-quinazolineamine and at least one other anti-neoplastic agent as well as a pharmaceutical combination including the 4-quinazolineamines. | 03-08-2012 |
20130310562 | Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors - A pharmaceutical formulation comprising the compound of formula | 11-21-2013 |
20150065527 | BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS - A pharmaceutical formulation comprising the compound of formula | 03-05-2015 |
20150366868 | CANCER TREATMENT METHOD - A method of treating cancer is described including administration of a 4-quinazolineamine and at least one other anti-neoplastic agent as well as a pharmaceutical combination including the 4-quinazolineamines. | 12-24-2015 |
20160051551 | BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS - A pharmaceutical formulation comprising the compound of formula | 02-25-2016 |